Compounds > fulvene
Page last updated: 2024-08-25

fulvene and Kidney Neoplasms

fulvene has been researched along with Kidney Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuffe, LP; Gallagher, WM; Lou, Y; Mendoza, O; Müller-Bunz, H; Rehmann, FJ; Sweeney, N; Tacke, M1
Strohfeldt, K; Tacke, M1

Reviews

1 review(s) available for fulvene and Kidney Neoplasms

ArticleYear
Bioorganometallic fulvene-derived titanocene anti-cancer drugs.
    Chemical Society reviews, 2008, Volume: 37, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Survival; Cyclopentanes; Drug Screening Assays, Antitumor; Inhibitory Concentration 50; Kidney Neoplasms; LLC-PK1 Cells; Molecular Structure; Organometallic Compounds; Swine

2008

Other Studies

1 other study(ies) available for fulvene and Kidney Neoplasms

ArticleYear
Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride.
    Journal of inorganic biochemistry, 2004, Volume: 98, Issue:12

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclopentanes; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Kidney Neoplasms; Molecular Conformation; Swine; Titanium

2004